We observed a similarly enhanced response in the 20 Gy/5F+USMB cohort (41.1±4.4%), suggesting that despite the preservation of the microvasculature as a result of ASMase knockout, primary tumour cell still responded to the fXRT+USMB treatments through a different mechanism (Fig. 5B). This evidence concerns the gene SMPD1 and neoplasm.